The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Injection Influenza Vaccine Market Research Report 2022

Global Injection Influenza Vaccine Market Research Report 2022

Publishing Date : Apr, 2022

License Type :
 

Report Code : 1689053

No of Pages : 92

Synopsis
Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.
Due to the COVID-19 pandemic, the global Injection Influenza Vaccine market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Injection Influenza Vaccine market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Injection Influenza Vaccine landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Trivalent Influenza Vaccine accounting for % of the Injection Influenza Vaccine global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While 6 Months to 3 Years segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
The global major manufacturers of Injection Influenza Vaccine include Sanofi, CSL, GSK, Viatris, AstraZeneca, Hualan Bio, Changchun Institute of Biological, Sinovac and Jiangsu GDK and etc. In terms of revenue, the global 3 largest players have a % market share of Injection Influenza Vaccine in 2021.
This report focuses on Injection Influenza Vaccine volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Injection Influenza Vaccine market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global Injection Influenza Vaccine Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Trivalent Influenza Vaccine
Quadrivalent Influenza Vaccine
Segment by Application
6 Months to 3 Years
> 3 Years
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Sanofi
CSL
GSK
Viatris
AstraZeneca
Hualan Bio
Changchun Institute of Biological
Sinovac
Jiangsu GDK
KM Biologics
Index
1 Injection Influenza Vaccine Market Overview
1.1 Product Overview and Scope of Injection Influenza Vaccine
1.2 Injection Influenza Vaccine Segment by Type
1.2.1 Global Injection Influenza Vaccine Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Trivalent Influenza Vaccine
1.2.3 Quadrivalent Influenza Vaccine
1.3 Injection Influenza Vaccine Segment by Application
1.3.1 Global Injection Influenza Vaccine Sales Comparison by Application: (2022-2028)
1.3.2 6 Months to 3 Years
1.3.3 > 3 Years
1.4 Global Injection Influenza Vaccine Market Size Estimates and Forecasts
1.4.1 Global Injection Influenza Vaccine Revenue 2017-2028
1.4.2 Global Injection Influenza Vaccine Sales 2017-2028
1.4.3 Injection Influenza Vaccine Market Size by Region: 2017 Versus 2021 Versus 2028
2 Injection Influenza Vaccine Market Competition by Manufacturers
2.1 Global Injection Influenza Vaccine Sales Market Share by Manufacturers (2017-2022)
2.2 Global Injection Influenza Vaccine Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Injection Influenza Vaccine Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Injection Influenza Vaccine Manufacturing Sites, Area Served, Product Type
2.5 Injection Influenza Vaccine Market Competitive Situation and Trends
2.5.1 Injection Influenza Vaccine Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Injection Influenza Vaccine Players Market Share by Revenue
2.5.3 Global Injection Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Injection Influenza Vaccine Retrospective Market Scenario by Region
3.1 Global Injection Influenza Vaccine Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Injection Influenza Vaccine Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Injection Influenza Vaccine Market Facts & Figures by Country
3.3.1 North America Injection Influenza Vaccine Sales by Country
3.3.2 North America Injection Influenza Vaccine Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Injection Influenza Vaccine Market Facts & Figures by Country
3.4.1 Europe Injection Influenza Vaccine Sales by Country
3.4.2 Europe Injection Influenza Vaccine Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Injection Influenza Vaccine Market Facts & Figures by Region
3.5.1 Asia Pacific Injection Influenza Vaccine Sales by Region
3.5.2 Asia Pacific Injection Influenza Vaccine Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Injection Influenza Vaccine Market Facts & Figures by Country
3.6.1 Latin America Injection Influenza Vaccine Sales by Country
3.6.2 Latin America Injection Influenza Vaccine Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.6.6 Colombia
3.7 Middle East and Africa Injection Influenza Vaccine Market Facts & Figures by Country
3.7.1 Middle East and Africa Injection Influenza Vaccine Sales by Country
3.7.2 Middle East and Africa Injection Influenza Vaccine Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Injection Influenza Vaccine Historic Market Analysis by Type
4.1 Global Injection Influenza Vaccine Sales Market Share by Type (2017-2022)
4.2 Global Injection Influenza Vaccine Revenue Market Share by Type (2017-2022)
4.3 Global Injection Influenza Vaccine Price by Type (2017-2022)
5 Global Injection Influenza Vaccine Historic Market Analysis by Application
5.1 Global Injection Influenza Vaccine Sales Market Share by Application (2017-2022)
5.2 Global Injection Influenza Vaccine Revenue Market Share by Application (2017-2022)
5.3 Global Injection Influenza Vaccine Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Corporation Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Injection Influenza Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Sanofi Injection Influenza Vaccine Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 CSL
6.2.1 CSL Corporation Information
6.2.2 CSL Description and Business Overview
6.2.3 CSL Injection Influenza Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.2.4 CSL Injection Influenza Vaccine Product Portfolio
6.2.5 CSL Recent Developments/Updates
6.3 GSK
6.3.1 GSK Corporation Information
6.3.2 GSK Description and Business Overview
6.3.3 GSK Injection Influenza Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.3.4 GSK Injection Influenza Vaccine Product Portfolio
6.3.5 GSK Recent Developments/Updates
6.4 Viatris
6.4.1 Viatris Corporation Information
6.4.2 Viatris Description and Business Overview
6.4.3 Viatris Injection Influenza Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Viatris Injection Influenza Vaccine Product Portfolio
6.4.5 Viatris Recent Developments/Updates
6.5 AstraZeneca
6.5.1 AstraZeneca Corporation Information
6.5.2 AstraZeneca Description and Business Overview
6.5.3 AstraZeneca Injection Influenza Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.5.4 AstraZeneca Injection Influenza Vaccine Product Portfolio
6.5.5 AstraZeneca Recent Developments/Updates
6.6 Hualan Bio
6.6.1 Hualan Bio Corporation Information
6.6.2 Hualan Bio Description and Business Overview
6.6.3 Hualan Bio Injection Influenza Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Hualan Bio Injection Influenza Vaccine Product Portfolio
6.6.5 Hualan Bio Recent Developments/Updates
6.7 Changchun Institute of Biological
6.6.1 Changchun Institute of Biological Corporation Information
6.6.2 Changchun Institute of Biological Description and Business Overview
6.6.3 Changchun Institute of Biological Injection Influenza Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Changchun Institute of Biological Injection Influenza Vaccine Product Portfolio
6.7.5 Changchun Institute of Biological Recent Developments/Updates
6.8 Sinovac
6.8.1 Sinovac Corporation Information
6.8.2 Sinovac Description and Business Overview
6.8.3 Sinovac Injection Influenza Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Sinovac Injection Influenza Vaccine Product Portfolio
6.8.5 Sinovac Recent Developments/Updates
6.9 Jiangsu GDK
6.9.1 Jiangsu GDK Corporation Information
6.9.2 Jiangsu GDK Description and Business Overview
6.9.3 Jiangsu GDK Injection Influenza Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Jiangsu GDK Injection Influenza Vaccine Product Portfolio
6.9.5 Jiangsu GDK Recent Developments/Updates
6.10 KM Biologics
6.10.1 KM Biologics Corporation Information
6.10.2 KM Biologics Description and Business Overview
6.10.3 KM Biologics Injection Influenza Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.10.4 KM Biologics Injection Influenza Vaccine Product Portfolio
6.10.5 KM Biologics Recent Developments/Updates
7 Injection Influenza Vaccine Manufacturing Cost Analysis
7.1 Injection Influenza Vaccine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Injection Influenza Vaccine
7.4 Injection Influenza Vaccine Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Injection Influenza Vaccine Distributors List
8.3 Injection Influenza Vaccine Customers
9 Injection Influenza Vaccine Market Dynamics
9.1 Injection Influenza Vaccine Industry Trends
9.2 Injection Influenza Vaccine Market Drivers
9.3 Injection Influenza Vaccine Market Challenges
9.4 Injection Influenza Vaccine Market Restraints
10 Global Market Forecast
10.1 Injection Influenza Vaccine Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Injection Influenza Vaccine by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Injection Influenza Vaccine by Type (2023-2028)
10.2 Injection Influenza Vaccine Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Injection Influenza Vaccine by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Injection Influenza Vaccine by Application (2023-2028)
10.3 Injection Influenza Vaccine Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Injection Influenza Vaccine by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Injection Influenza Vaccine by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
List of Tables
Table 1. Global Injection Influenza Vaccine Sales Growth Rate Comparison by Type (2022-2028) & (Units) & (US$ Million)
Table 2. Global Injection Influenza Vaccine Sales Growth Rate Comparison by Application (2022-2028) & (Units) & (US$ Million)
Table 3. Global Injection Influenza Vaccine Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Injection Influenza Vaccine Market Competitive Situation by Manufacturers in 2021
Table 5. Global Injection Influenza Vaccine Sales (Units) of Key Manufacturers (2017-2022)
Table 6. Global Injection Influenza Vaccine Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Injection Influenza Vaccine Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Injection Influenza Vaccine Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Injection Influenza Vaccine Average Price (US$/Unit) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Injection Influenza Vaccine Manufacturing Sites and Area Served
Table 11. Manufacturers Injection Influenza Vaccine Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Injection Influenza Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Injection Influenza Vaccine as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Injection Influenza Vaccine Sales by Region (2017-2022) & (Units)
Table 16. Global Injection Influenza Vaccine Sales Market Share by Region (2017-2022)
Table 17. Global Injection Influenza Vaccine Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Injection Influenza Vaccine Revenue Market Share by Region (2017-2022)
Table 19. North America Injection Influenza Vaccine Sales by Country (2017-2022) & (Units)
Table 20. North America Injection Influenza Vaccine Sales Market Share by Country (2017-2022)
Table 21. North America Injection Influenza Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Injection Influenza Vaccine Revenue Market Share by Country (2017-2022)
Table 23. Europe Injection Influenza Vaccine Sales by Country (2017-2022) & (Units)
Table 24. Europe Injection Influenza Vaccine Sales Market Share by Country (2017-2022)
Table 25. Europe Injection Influenza Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Injection Influenza Vaccine Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Injection Influenza Vaccine Sales by Region (2017-2022) & (Units)
Table 28. Asia Pacific Injection Influenza Vaccine Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Injection Influenza Vaccine Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Injection Influenza Vaccine Revenue Market Share by Region (2017-2022)
Table 31. Latin America Injection Influenza Vaccine Sales by Country (2017-2022) & (Units)
Table 32. Latin America Injection Influenza Vaccine Sales Market Share by Country (2017-2022)
Table 33. Latin America Injection Influenza Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Injection Influenza Vaccine Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Injection Influenza Vaccine Sales by Country (2017-2022) & (Units)
Table 36. Middle East and Africa Injection Influenza Vaccine Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Injection Influenza Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Injection Influenza Vaccine Revenue Market Share by Country (2017-2022)
Table 39. Global Injection Influenza Vaccine Sales by Type (2017-2022) & (Units)
Table 40. Global Injection Influenza Vaccine Sales Market Share by Type (2017-2022)
Table 41. Global Injection Influenza Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Injection Influenza Vaccine Revenue Share by Type (2017-2022)
Table 43. Global Injection Influenza Vaccine Price by Type (2017-2022) & (US$/Unit)
Table 44. Global Injection Influenza Vaccine Sales (Units) by Application (2017-2022)
Table 45. Global Injection Influenza Vaccine Sales Market Share by Application (2017-2022)
Table 46. Global Injection Influenza Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Injection Influenza Vaccine Revenue Share by Application (2017-2022)
Table 48. Global Injection Influenza Vaccine Price by Application (2017-2022) & (US$/Unit)
Table 49. Sanofi Corporation Information
Table 50. Sanofi Description and Business Overview
Table 51. Sanofi Injection Influenza Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 52. Sanofi Injection Influenza Vaccine Product
Table 53. Sanofi Recent Developments/Updates
Table 54. CSL Corporation Information
Table 55. CSL Description and Business Overview
Table 56. CSL Injection Influenza Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 57. CSL Injection Influenza Vaccine Product
Table 58. CSL Recent Developments/Updates
Table 59. GSK Corporation Information
Table 60. GSK Description and Business Overview
Table 61. GSK Injection Influenza Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 62. GSK Injection Influenza Vaccine Product
Table 63. GSK Recent Developments/Updates
Table 64. Viatris Corporation Information
Table 65. Viatris Description and Business Overview
Table 66. Viatris Injection Influenza Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 67. Viatris Injection Influenza Vaccine Product
Table 68. Viatris Recent Developments/Updates
Table 69. AstraZeneca Corporation Information
Table 70. AstraZeneca Description and Business Overview
Table 71. AstraZeneca Injection Influenza Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 72. AstraZeneca Injection Influenza Vaccine Product
Table 73. AstraZeneca Recent Developments/Updates
Table 74. Hualan Bio Corporation Information
Table 75. Hualan Bio Description and Business Overview
Table 76. Hualan Bio Injection Influenza Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 77. Hualan Bio Injection Influenza Vaccine Product
Table 78. Hualan Bio Recent Developments/Updates
Table 79. Changchun Institute of Biological Corporation Information
Table 80. Changchun Institute of Biological Description and Business Overview
Table 81. Changchun Institute of Biological Injection Influenza Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 82. Changchun Institute of Biological Injection Influenza Vaccine Product
Table 83. Changchun Institute of Biological Recent Developments/Updates
Table 84. Sinovac Corporation Information
Table 85. Sinovac Description and Business Overview
Table 86. Sinovac Injection Influenza Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 87. Sinovac Injection Influenza Vaccine Product
Table 88. Sinovac Recent Developments/Updates
Table 89. Jiangsu GDK Corporation Information
Table 90. Jiangsu GDK Description and Business Overview
Table 91. Jiangsu GDK Injection Influenza Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 92. Jiangsu GDK Injection Influenza Vaccine Product
Table 93. Jiangsu GDK Recent Developments/Updates
Table 94. KM Biologics Corporation Information
Table 95. KM Biologics Description and Business Overview
Table 96. KM Biologics Injection Influenza Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 97. KM Biologics Injection Influenza Vaccine Product
Table 98. KM Biologics Recent Developments/Updates
Table 99. Production Base and Market Concentration Rate of Raw Material
Table 100. Key Suppliers of Raw Materials
Table 101. Injection Influenza Vaccine Distributors List
Table 102. Injection Influenza Vaccine Customers List
Table 103. Injection Influenza Vaccine Market Trends
Table 104. Injection Influenza Vaccine Market Drivers
Table 105. Injection Influenza Vaccine Market Challenges
Table 106. Injection Influenza Vaccine Market Restraints
Table 107. Global Injection Influenza Vaccine Sales Forecast by Type (2023-2028) & (Units)
Table 108. Global Injection Influenza Vaccine Sales Market Share Forecast by Type (2023-2028)
Table 109. Global Injection Influenza Vaccine Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 110. Global Injection Influenza Vaccine Revenue Market Share Forecast by Type (2023-2028)
Table 111. Global Injection Influenza Vaccine Sales Forecast by Application (2023-2028) & (Units)
Table 112. Global Injection Influenza Vaccine Sales Market Share Forecast by Application (2023-2028)
Table 113. Global Injection Influenza Vaccine Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 114. Global Injection Influenza Vaccine Revenue Market Share Forecast by Application (2023-2028)
Table 115. Global Injection Influenza Vaccine Sales Forecast by Region (2023-2028) & (Units)
Table 116. Global Injection Influenza Vaccine Sales Market Share Forecast by Region (2023-2028)
Table 117. Global Injection Influenza Vaccine Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 118. Global Injection Influenza Vaccine Revenue Market Share Forecast by Region (2023-2028)
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Injection Influenza Vaccine
Figure 2. Global Injection Influenza Vaccine Market Share by Type in 2021 & 2028
Figure 3. Trivalent Influenza Vaccine Product Picture
Figure 4. Quadrivalent Influenza Vaccine Product Picture
Figure 5. Global Injection Influenza Vaccine Market Share by Application in 2021 & 2028
Figure 6. 6 Months to 3 Years
Figure 7. > 3 Years
Figure 8. Global Injection Influenza Vaccine Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 9. Global Injection Influenza Vaccine Market Size (2017-2028) & (US$ Million)
Figure 10. Global Injection Influenza Vaccine Sales (2017-2028) & (Units)
Figure 11. Injection Influenza Vaccine Sales Share by Manufacturers in 2021
Figure 12. Global Injection Influenza Vaccine Revenue Share by Manufacturers in 2021
Figure 13. The Global 5 and 10 Largest Injection Influenza Vaccine Players: Market Share by Revenue in 2021
Figure 14. Injection Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 15. Global Injection Influenza Vaccine Sales Market Share by Region (2017-2022)
Figure 16. Global Injection Influenza Vaccine Sales Market Share by Region in 2021
Figure 17. Global Injection Influenza Vaccine Revenue Market Share by Region (2017-2022)
Figure 18. Global Injection Influenza Vaccine Revenue Market Share by Region in 2021
Figure 19. United States Injection Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 20. Canada Injection Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 21. Germany Injection Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 22. France Injection Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 23. U.K. Injection Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. Italy Injection Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. Russia Injection Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. China Injection Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. Japan Injection Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. South Korea Injection Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. India Injection Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. Australia Injection Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. China Taiwan Injection Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. Indonesia Injection Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. Thailand Injection Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. Malaysia Injection Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Mexico Injection Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Brazil Injection Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Argentina Injection Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Colombia Injection Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Turkey Injection Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Saudi Arabia Injection Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. UAE Injection Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Sales Market Share of Injection Influenza Vaccine by Type (2017-2022)
Figure 43. Manufacturing Cost Structure of Injection Influenza Vaccine
Figure 44. Manufacturing Process Analysis of Injection Influenza Vaccine
Figure 45. Injection Influenza Vaccine Industrial Chain Analysis
Figure 46. Channels of Distribution
Figure 47. Distributors Profiles
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’